health
Trial eligibility can make genetic scores appear to predict treatment response
A medRxiv preprint reports that trial eligibility criteria can create apparent differences in lipid-lowering treatment response by polygenic risk score, even when the true genetic interaction is set to zero. Its cohort analyses found little evidence that coronary artery disease risk scores modified statin effects.